Literature DB >> 29151103

Immunoregulatory Role of Cannabinoids during Infectious Disease.

Rosalía Hernández-Cervantes1, Mónica Méndez-Díaz, Óscar Prospéro-García, Jorge Morales-Montor.   

Abstract

Although the endocannabinoid system (ECS) is involved in the regulation of several physiological processes, including sleep and the immune response, its role during infections has not been fully studied. It is well known that the use of this drug increases susceptibility to infections because of the impact on the modulation of the immune system. Concerning the medicinal or recreational use of marijuana, its influence on the course of an infection, whether this has been caused by bacteria, viruses, parasites, and to a lesser degree, fungi, has been reported. Furthermore, there is evidence suggesting the involvement of the ECS in the control and elimination of infectious agents such as bacteria, viruses, and some protozoa; in the case of fungi, few studies are available so far. The purpose of this review is to present the existing studies related to infections and the ECS, the microbicidal effects of compounds isolated from Cannabis sativa, and the association between marijuana use and the development of rare pathologies in specific diseases.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Bacteria; Endocannabinoids; Infections; Parasites; Virus

Mesh:

Substances:

Year:  2017        PMID: 29151103     DOI: 10.1159/000481824

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  30 in total

1.  Modulation of mean arterial pressure and diuresis by renomedullary infusion of a selective inhibitor of fatty acid amide hydrolase.

Authors:  Ashfaq Ahmad; Sara K Dempsey; Zdravka Daneva; Ningjun Li; Justin L Poklis; Pin-Lan Li; Joseph K Ritter
Journal:  Am J Physiol Renal Physiol       Date:  2018-05-30

2.  Potential Probiotic or Trigger of Gut Inflammation - The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract.

Authors:  Charles M Skinner; Intawat Nookaew; Laura E Ewing; Thidathip Wongsurawat; Piroon Jenjaroenpun; Charles M Quick; Eric U Yee; Brian D Piccolo; Mahmoud ElSohly; Larry A Walker; Bill Gurley; Igor Koturbash
Journal:  J Diet Suppl       Date:  2020-05-13

Review 3.  Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain.

Authors:  Barbara Stella; Francesca Baratta; Carlo Della Pepa; Silvia Arpicco; Daniela Gastaldi; Franco Dosio
Journal:  Drugs       Date:  2021-09-04       Impact factor: 9.546

4.  Substance use is independently associated with pneumonia severity in persons living with the human immunodeficiency virus (HIV).

Authors:  Sarah E Jolley; David A Welsh
Journal:  Subst Abus       Date:  2019-03-18       Impact factor: 3.716

5.  β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19.

Authors:  Niraj Kumar Jha; Charu Sharma; Hebaallah Mamdouh Hashiesh; Seenipandi Arunachalam; Mf Nagoor Meeran; Hayate Javed; Chandragouda R Patil; Sameer N Goyal; Shreesh Ojha
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

Review 6.  Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?

Authors:  Francesca Rossi; Chiara Tortora; Maura Argenziano; Alessandra Di Paola; Francesca Punzo
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

Review 7.  Cannabis, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back.

Authors:  Osnat Almogi-Hazan; Reuven Or
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

8.  Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles.

Authors:  Uchini S Kosgodage; Paul Matewele; Brigitte Awamaria; Igor Kraev; Purva Warde; Giulia Mastroianni; Alistair V Nunn; Geoffrey W Guy; Jimmy D Bell; Jameel M Inal; Sigrun Lange
Journal:  Front Cell Infect Microbiol       Date:  2019-09-10       Impact factor: 5.293

Review 9.  Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug-Drug Interactions.

Authors:  Joshua D Brown
Journal:  J Clin Med       Date:  2020-03-27       Impact factor: 4.241

10.  Potential combinations of endocannabinoid/endocannabinoid-like compounds and antibiotics against methicillin-resistant Staphylococcus aureus.

Authors:  Mark Feldman; Reem Smoum; Raphael Mechoulam; Doron Steinberg
Journal:  PLoS One       Date:  2020-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.